Jacob Waxman

2.0k total citations · 2 hit papers
14 papers, 1.3k citations indexed

About

Jacob Waxman is a scholar working on Surgery, Infectious Diseases and Oncology. According to data from OpenAlex, Jacob Waxman has authored 14 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Surgery, 3 papers in Infectious Diseases and 3 papers in Oncology. Recurrent topics in Jacob Waxman's work include SARS-CoV-2 and COVID-19 Research (3 papers), Acute Myeloid Leukemia Research (2 papers) and Eosinophilic Esophagitis (2 papers). Jacob Waxman is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (3 papers), Acute Myeloid Leukemia Research (2 papers) and Eosinophilic Esophagitis (2 papers). Jacob Waxman collaborates with scholars based in Israel, United Kingdom and United States. Jacob Waxman's co-authors include Ran D. Balicer, Doron Netzer, Noa Dagan, Yatir Ben‐Shlomo, Noam Barda, Ben Y. Reis, Eldad Kepten, Marc Lipsitch, Reut Ohana and Miguel A. Hernán and has published in prestigious journals such as New England Journal of Medicine, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Jacob Waxman

14 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting

2021 672 citations Noam Barda, Noa Dagan et al. New England Journal of Medicine profile →
Nirmatrelvir Use and Severe Covid-19 Outcomes during the Omicron Surge

2022 197 citations Ronen Arbel, Yael Wolff Sagy et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jacob Waxman Israel	9	660	357	260	218	199	14	1.3k
Martina Patone United Kingdom	12	835 1.3×	312 0.9×	127 0.5×	39 0.2×	295 1.5×	24	1.3k
Xue W. Mei United Kingdom	9	735 1.1×	299 0.8×	121 0.5×	28 0.1×	286 1.4×	17	1.2k
Julien Favresse Belgium	22	816 1.2×	147 0.4×	117 0.5×	33 0.2×	163 0.8×	77	1.5k
Paolo Sacchi Italy	24	828 1.3×	169 0.5×	808 3.1×	36 0.2×	77 0.4×	115	2.2k
Stefania Vaglio Italy	25	445 0.7×	202 0.6×	168 0.6×	80 0.4×	54 0.3×	71	2.0k
Arnaud Del Bello France	25	1.1k 1.7×	577 1.6×	465 1.8×	42 0.2×	32 0.2×	101	2.4k
P. Blanche France	17	193 0.3×	143 0.4×	272 1.0×	29 0.1×	181 0.9×	67	1.2k
Wai Fu Ng China	14	1.2k 1.9×	112 0.3×	466 1.8×	105 0.5×	54 0.3×	21	2.6k
Shyamasundaran Kottilil United States	23	604 0.9×	169 0.5×	1.1k 4.1×	46 0.2×	155 0.8×	67	2.5k

Countries citing papers authored by Jacob Waxman

Since Specialization

Citations

This map shows the geographic impact of Jacob Waxman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacob Waxman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacob Waxman more than expected).

Fields of papers citing papers by Jacob Waxman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacob Waxman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacob Waxman. The network helps show where Jacob Waxman may publish in the future.

Co-authorship network of co-authors of Jacob Waxman

This figure shows the co-authorship network connecting the top 25 collaborators of Jacob Waxman. A scholar is included among the top collaborators of Jacob Waxman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacob Waxman. Jacob Waxman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

1.

Waxman, Jacob, Ben Y. Reis, Doron Netzer, et al.. (2022). Comparing COVID-19-related hospitalization rates among individuals with infection-induced and vaccine-induced immunity in Israel. Nature Communications. 13(1). 2202–2202. 16 indexed citations

2.

Arbel, Ronen, Yael Wolff Sagy, Moshe Hoshen, et al.. (2022). Nirmatrelvir Use and Severe Covid-19 Outcomes during the Omicron Surge. New England Journal of Medicine. 387(9). 790–798. 197 indexed citations breakdown →

3.

Barda, Noam, Noa Dagan, Yatir Ben‐Shlomo, et al.. (2021). Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting. New England Journal of Medicine. 385(12). 1078–1090. 672 indexed citations breakdown →

4.

Kharenko, Oleg, et al.. (2016). Long-term outcome of neonates with suspected Hirschsprung’s disease, but normal rectal biopsy. European Journal of Gastroenterology & Hepatology. 28(8). 917–922. 1 indexed citations

5.

Shilo, Dekel, Jacob Waxman, Ron Shahar, et al.. (2016). Skeletal ligament healing using the recombinant human amelogenin protein. Journal of Cellular and Molecular Medicine. 20(5). 815–824. 10 indexed citations

6.

Kasirer, Yair, et al.. (2013). Scalloping is a reliable endoscopic marker for celiac disease. Digestive Endoscopy. 26(2). 232–235. 5 indexed citations

7.

Turner, Dan, Anne M. Griffiths, Thomas D. Walters, et al.. (2011). Mathematical weighting of the pediatric Crohnʼs disease activity index (PCDAI) and comparison with its other short versions. Inflammatory Bowel Diseases. 18(1). 55–62. 213 indexed citations

8.

Papamichael, D., et al.. (1997). Phase II study of paclitaxel in pretreated patients with locally advanced/metastatic cancer of the bladder and ureter. British Journal of Cancer. 75(4). 606–607. 94 indexed citations

9.

Bengtsson, Nils‐Olof, C Focan, A. Gudgeon, et al.. (1997). A phase III trial comparing vorozole (RIVIZOR™) versus aminoglutethimlde in the treatment of advanced postmenopausal breast cancer. European Journal of Cancer. 33. S148–S148. 10 indexed citations

10.

Waxman, Jacob, et al.. (1996). Quinolone Allergy?. Annals of Allergy Asthma & Immunology. 77(4). 273–276. 5 indexed citations

11.

Levi, S, C.S. Foster, H J Hodgson, et al.. (1993). Chronic liver disease due to hepatitis C.. BMJ. 306(6884). 1054–1056. 5 indexed citations

12.

Saini, Aman & Jacob Waxman. (1992). Chemotherapy for gastric cancer.. Gut. 33(9). 1153–1154. 9 indexed citations

13.

Rohatiner, A. Z. S., Walter M. Gregory, Renato Bassan, et al.. (1988). Short-term therapy for acute myelogenous leukemia.. Journal of Clinical Oncology. 6(2). 218–226. 29 indexed citations

14.

Ta, Lister, Renato Bassan, Walter M. Gregory, et al.. (1987). Conventional dose cytosine arabinoside in combination chemotherapy for acute myelogenous leukemia.. PubMed. 14(2 Suppl 1). 53–4. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact